Exact Mass: 567.3195860000001
Exact Mass Matches: 567.3195860000001
Found 339 metabolites which its exact mass value is equals to given mass value 567.3195860000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nelfinavir
C32H45N3O4S (567.3130610000001)
Nelfinavir is only found in individuals that have used or taken this drug. It is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. [PubChem]Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
LysoPC(22:6/0:0)
LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position. The docosahexaenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position. The docosahexaenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
1-Heneicosanoyl-glycero-3-phosphoserine
4-Hprog
Penitrem D
4-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-2,3-dimethylbenzoyl]-methylamino]-5-methoxy-2,2,3,3,4-pentamethyl-5-oxopentanoic acid
Nelfinavir
C32H45N3O4S (567.3130610000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Phe Phe Arg Val
Phe Phe Val Arg
Phe His His Lys
Phe His Lys His
Phe Lys His His
Phe Arg Phe Val
Phe Arg Val Phe
Phe Val Phe Arg
Phe Val Arg Phe
His Phe His Lys
His Phe Lys His
His His Phe Lys
His His Lys Phe
His Ile Ile Trp
His Ile Leu Trp
His Ile Trp Ile
His Ile Trp Leu
His Lys Phe His
His Lys His Phe
His Lys Lys Arg
His Lys Gln Arg
His Lys Arg Lys
His Lys Arg Gln
His Leu Ile Trp
His Leu Leu Trp
His Leu Trp Ile
His Leu Trp Leu
His Gln Lys Arg
His Gln Gln Arg
C22H37N11O7 (567.2877292000001)
His Gln Arg Lys
His Gln Arg Gln
C22H37N11O7 (567.2877292000001)
His Arg Lys Lys
His Arg Lys Gln
His Arg Gln Lys
His Arg Gln Gln
C22H37N11O7 (567.2877292000001)
His Trp Ile Ile
His Trp Ile Leu
His Trp Leu Ile
His Trp Leu Leu
Ile His Ile Trp
Ile His Leu Trp
Ile His Trp Ile
Ile His Trp Leu
Ile Ile His Trp
Ile Ile Trp His
Ile Leu His Trp
Ile Leu Trp His
Ile Trp His Ile
Ile Trp His Leu
Ile Trp Ile His
Ile Trp Leu His
Lys Phe His His
Lys His Phe His
Lys His His Phe
Lys His Lys Arg
Lys His Gln Arg
Lys His Arg Lys
Lys His Arg Gln
Lys Lys His Arg
Lys Lys Arg His
Lys Gln His Arg
Lys Gln Arg His
Lys Arg His Lys
Lys Arg His Gln
Lys Arg Lys His
Lys Arg Gln His
Leu His Ile Trp
Leu His Leu Trp
Leu His Trp Ile
Leu His Trp Leu
Leu Ile His Trp
Leu Ile Trp His
Leu Leu His Trp
Leu Leu Trp His
Leu Trp His Ile
Leu Trp His Leu
Leu Trp Ile His
Leu Trp Leu His
Met Arg Val Tyr
C25H41N7O6S (567.2838886000001)
Met Arg Tyr Val
C25H41N7O6S (567.2838886000001)
Met Val Arg Tyr
C25H41N7O6S (567.2838886000001)
Met Val Tyr Arg
C25H41N7O6S (567.2838886000001)
Met Tyr Arg Val
C25H41N7O6S (567.2838886000001)
Met Tyr Val Arg
C25H41N7O6S (567.2838886000001)
Gln His Lys Arg
Gln His Gln Arg
C22H37N11O7 (567.2877292000001)
Gln His Arg Lys
Gln His Arg Gln
C22H37N11O7 (567.2877292000001)
Gln Lys His Arg
Gln Lys Arg His
Gln Gln His Arg
C22H37N11O7 (567.2877292000001)
Gln Gln Arg His
C22H37N11O7 (567.2877292000001)
Gln Arg His Lys
Gln Arg His Gln
C22H37N11O7 (567.2877292000001)
Gln Arg Lys His
Gln Arg Gln His
C22H37N11O7 (567.2877292000001)
Arg Phe Phe Val
Arg Phe Val Phe
Arg His Lys Lys
Arg His Lys Gln
Arg His Gln Lys
Arg His Gln Gln
C22H37N11O7 (567.2877292000001)
Arg Lys His Lys
Arg Lys His Gln
Arg Lys Lys His
Arg Lys Gln His
Arg Met Val Tyr
C25H41N7O6S (567.2838886000001)
Arg Met Tyr Val
C25H41N7O6S (567.2838886000001)
Arg Gln His Lys
Arg Gln His Gln
C22H37N11O7 (567.2877292000001)
Arg Gln Lys His
Arg Gln Gln His
C22H37N11O7 (567.2877292000001)
Arg Val Phe Phe
Arg Val Met Tyr
C25H41N7O6S (567.2838886000001)
Arg Val Tyr Met
C25H41N7O6S (567.2838886000001)
Arg Tyr Met Val
C25H41N7O6S (567.2838886000001)
Arg Tyr Val Met
C25H41N7O6S (567.2838886000001)
Val Phe Phe Arg
Val Phe Arg Phe
Val Met Arg Tyr
C25H41N7O6S (567.2838886000001)
Val Met Tyr Arg
C25H41N7O6S (567.2838886000001)
Val Arg Phe Phe
Val Arg Met Tyr
C25H41N7O6S (567.2838886000001)
Val Arg Tyr Met
C25H41N7O6S (567.2838886000001)
Val Tyr Met Arg
C25H41N7O6S (567.2838886000001)
Val Tyr Arg Met
C25H41N7O6S (567.2838886000001)
Trp His Ile Ile
Trp His Ile Leu
Trp His Leu Ile
Trp His Leu Leu
Trp Ile His Ile
Trp Ile His Leu
Trp Ile Ile His
Trp Ile Leu His
Trp Leu His Ile
Trp Leu His Leu
Trp Leu Ile His
Trp Leu Leu His
Tyr Met Arg Val
C25H41N7O6S (567.2838886000001)
Tyr Met Val Arg
C25H41N7O6S (567.2838886000001)
Tyr Arg Met Val
C25H41N7O6S (567.2838886000001)
Tyr Arg Val Met
C25H41N7O6S (567.2838886000001)
Tyr Val Met Arg
C25H41N7O6S (567.2838886000001)
Tyr Val Arg Met
C25H41N7O6S (567.2838886000001)
PC(22:6/0:0)[U]
PC(22:6/0:0)
Didecanoylphosphatidylserine
cataCXium(R) FPrPh,Dicyclohexyl[9-(3-phenylpropyl)-9-fluorenyl]phosphine tetrafluoroborate
C34H41BF4P (567.2974893999999)
7-[4-(diethylamino)-2-ethoxyphenyl]-7-(2-methyl-1-octylindol-3-yl)furo[3,4-b]pyridin-5-one
C36H45N3O3 (567.3460739999999)
HG-9-91-01
3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide
rel-sodium 2-((1S,4R,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-acetoxy-1,4-dimethoxy-5b,8,8,11a,13a-pentamethyl-3-oxo-5,5a,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-phenanthro[2,1-e]isoindol-2(3H,4H,5bH)-yl)acetate
A natural product found in Hyattella species.
2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and is located at position 2.
1-O-(3alpha,7alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-O-(3alpha,12alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-O-(3alpha,6alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
N-[(2R,3S)-2-[[[anilino(oxo)methyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide
3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
C32H45N3O4S (567.3130610000001)
[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-Amino-3-[2,3-di(decanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
(4E,8E,12E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid
2-Amino-3-[(3-decoxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-undecoxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] propanoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
2-Amino-3-[hydroxy-(3-nonanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-heptadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-pentadecanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-dodecanoyloxy-3-octanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-hexanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-octadecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
(E)-N-[2-[2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-3,4-dihydroxy-3,4-dihydro-2H-pyran-5-yl]dodec-2-enamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]propanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]acetamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]pentanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]butanamide
helvolate
The steroid acid anion formed by loss of a proton from the carboxy group of helvolic acid; major microspecies at pH 7.3.
1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the remaining acyl group is (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl.
N-tert-butyl-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
C32H45N3O4S (567.3130610000001)
1-palmitoyl-2-glutaryl-sn-glycero-phosphoethanolamine
lysophosphatidylcholine 22:6
An acyl-sn-glycero-3-phosphocholine in which the acyl group (position not specified) contains 22 carbons with 6 double bonds.
1-Docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the docosahexaenoyl group is located at position 1.
2-docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the acyl group is specified as docosahexaenoyl and is located at position 2.
chenodeoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of chenodeoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
deoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of deoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
hyodeoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of hyodeoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
(1s,2r,3r,4s,5r,6s,8r,9r,10r,13s,16s,17r,18r)-11-ethyl-8,18-dihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl (2e)-3-phenylprop-2-enoate
(1s,2r,5s,8r,9r,11s,14r,15s,24s,26s,27s)-14,15,32,32-tetramethyl-23-methylidene-9-(prop-1-en-2-yl)-10,31-dioxa-17-azanonacyclo[24.4.2.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁶,³⁰.0¹⁸,²⁹.0²¹,²⁸.0²⁴,²⁷]dotriaconta-6,16(30),18,20,28-pentaene-5,8-diol
18-(acetyloxy)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
(3s,6s,9r,12s)-19-butyl-5,8,11,14,17-pentahydroxy-3,12-diisopropyl-6-methyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one
2-hydroxy-1-(2-hydroxyethyl)-2,4-dimethyl-5-[(5z,7e,9e,11e)-2,4,14-trihydroxy-9,13,15-trimethyl-17-phenylheptadeca-5,7,9,11-tetraen-1-yl]pyrrol-3-one
19-hexyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,6-dimethyl-9-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one
2,3,23,23,25,25-hexamethyl-8-(prop-1-en-2-yl)-7,24-dioxa-31-azaoctacyclo[15.14.0.0²,¹⁵.0³,¹².0⁶,¹¹.0¹⁸,³⁰.0²⁰,²⁸.0²²,²⁷]hentriaconta-1(17),10,18,20(28),21,26,29-heptaene-9,12-diol
(2r,3s,4s,5s,6r)-2-(hydroxymethyl)-6-{[(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-yl]oxy}oxane-3,4,5-triol
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-4-(acetyloxy)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl benzoate
5,8,11,14,17-pentahydroxy-3,12-diisopropyl-6-methyl-9-(2-methylpropyl)-19-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one
11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3-phenylprop-2-enoate
14-o-cinnamoylneoline
{"Ingredient_id": "HBIN001538","Ingredient_name": "14-o-cinnamoylneoline","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "C1=CC(=CN=C1)C2=CC3=NC(=NN3C(=N2)N)C4=CC=CO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14681","TCMID_id": "3713","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-veratroyl-17-acetyl-19-oxodictizine
{"Ingredient_id": "HBIN001727","Ingredient_name": "15-veratroyl-17-acetyl-19-oxodictizine","Alias": "NA","Ingredient_formula": "C32H41NO8","Ingredient_Smile": "CC(=O)OCC1(C2CCC3(C1OC(=O)C4=CC(=C(C=C4)OC)OC)C5CC6C7(CCCC6(C3C2)C5N(C7=O)C)C)O","Ingredient_weight": "567.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22375","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579305","DrugBank_id": "NA"}
2-deacetoxyl-10-acetoxytaxine b
{"Ingredient_id": "HBIN005495","Ingredient_name": "2-deacetoxyl-10-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26043","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetoxyl-9-acetoxytaxine b
{"Ingredient_id": "HBIN005496","Ingredient_name": "2-deacetoxyl-9-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26044","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyl-10-acetyltaxine b
{"Ingredient_id": "HBIN005500","Ingredient_name": "2-deacetyl-10-acetyltaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4712","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyl-9-acetoxytaxine b
{"Ingredient_id": "HBIN005502","Ingredient_name": "2-deacetyl-9-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4710","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-o-cinnamoylneoline
{"Ingredient_id": "HBIN013852","Ingredient_name": "8-o-cinnamoylneoline","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C=CC7=CC=CC=C7)OC)O)OC)O)COC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3712","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}